文献速递衰弱、肌少症与跌倒老年综合评估

STEADI Options 随机质量改进试验预防老年人跌倒的成本效果

The cost-effectiveness of the stopping elderly accidents, deaths and injuries options randomised quality improvement trial to prevent falls among older adults.
PubMed 文献 · Age Ageing · 2026-01-01

本研究基于 STEADI Options 随机试验,模拟远程医疗实施 CDC 跌倒预防倡议在 65 岁以上跌倒风险增高人群中的成本效果。从医疗 payer 视角、1 年时间跨度、0% 贴现率分析,干预组累计成本减少 873 美元,医疗系统内治疗跌倒减少 0.037 次,增量净效益为 1995 美元/入组者,在 82.9% 的模拟中具有成本效果。但医疗治疗跌倒和总医疗成本的差异无统计学意义,不能排除干预无效的可能。

要点

  • 干预组累计成本减少 873 美元(95% U.I. -3839 至 2081)。
  • 医疗系统内治疗跌倒减少 0.037 次(95% C.I. -0.090 至 0.015)。
  • 增量净效益 1995 美元/入组者,82.9% 模拟具成本效果。

核心结论

  • 在研究队列内,干预极可能具有成本效果,但不能排除干预无影响的可能性。

研究设计与样本

  • 基于 STEADI Options 随机试验及已发表数据,从医疗 payer 视角模拟干预与标准护理的成本效果,时间跨度 1 年,贴现率 0%。

主要发现

  • 与对照组相比,干预组累计成本减少 873 美元(95% U.I. -3839 至 2081)。
  • 医疗系统内治疗跌倒减少 0.037 次(95% C.I. -0.090 至 0.015),其他提供者治疗跌倒减少 0.007 次(95% C.I. -0.070 至 0.053)。
  • 增量净效益为 1995 美元/入组者(95% U.I. -2166 至 6118),在 71.8% 的模拟中节约成本,在 82.9% 的模拟中具有成本效果。

临床怎么用

  • 在 65 岁以上跌倒风险增高的老年人中,远程医疗实施 STEADI 跌倒预防干预可能节约成本并具有成本效果。
  • 鉴于医疗治疗跌倒和总医疗成本差异无统计学意义,临床决策需结合其他证据综合判断。

局限性

  • 医疗治疗跌倒和总医疗成本的差异无统计学意义,不能排除干预无影响的可能性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Stopping Elderly Accidents, Deaths, and Injuries (STEADI) Options was a randomized trial of a telemedicine implementation of the CDC's STEADI older adult fall prevention initiative implemented among adults ages 65 and older at increased risk for falls. METHODS: Using STEADI Options and published data, we simulated the intervention's cost-effectiveness as compared to standard of care from the healthcare payer's perspective, over a one-year time horizon with a 0% discount rate. Using an incremental net benefit (INB) framework we estimated cost-effectiveness assuming a baseline willingness-to-pay (WTP) of $25 478 to prevent one medically treated fall and performed univariate and probabilistic sensitivity analyses. RESULTS: Cumulatively when compared to the control participants, those in the intervention cost -$873 (95% U.I. -$3839, $2081) less, experienced fewer falls treated within the healthcare system -0.037 (95% Confidence interval (C.I.), -0.090, 0.015), and fewer falls treated by other providers -0.007 (95% C.I. -0.070, 0.053). The intervention's INB of $1995 (95% U.I. -$2166, $6118) per enrollee, was cost saving in 71.8% of simulations and cost-effective in 82.9% of simulations. Cost-effectiveness was insensitive to wide changes in the model's parameters, was cost-effective in 71.8% of simulations at a WTP of $0 and 85.4% of simulations at a WTP of $50 000. CONCLUSION: Within the study cohort, the intervention was highly likely to be cost-effective. However, differences in medically treated falls and total healthcare costs were not statistically significant; therefore, we cannot rule out the possibility that the intervention had no impact.

来源:Age Ageing,查看原文。版权归原作者所有。

引用

  1. Rein DB, Peterson C, Brault MW, et al. The cost-effectiveness of the stopping elderly accidents, deaths and injuries options randomised quality improvement trial to prevent falls among older adults. Age Ageing. 2026. PMID: 42315165. doi:10.1093/ageing/afag141

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。